XCELL PRP
Commercial- Indications
- Regenerative medicine
Company intelligence / Profile preview
APEX Biologix
Woods Cross, Utah, United Statesapexbiologix.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Commercial
01
Overview
APEX Biologix has developed and commercialized FDA-cleared Class II medical devices for regenerative medicine, including the XCELL PRP kit. The company’s products are widely used in orthopedics, sports medicine, and wound care. They have expanded into Europe and veterinary markets, with over 2,000 active physician clients globally. Clinical results focus on consistent platelet concentration and streamlined procedures for improved patient outcomes.
- Therapeutic areas
- OtherDermatology
- Modalities
- Platelet-rich plasma (PRP) therapy (Biologic)Bone marrow concentrate therapy (Biologic)Protein concentrate therapy (Biologic)Allograft products (Biologic)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Mayo Clinic – know-how license agreement for regenerative product developmentBioventus LLC – exclusive U.S. distribution agreement for the XCELL PRP system in orthopedics/sports medicine
Beyond the preview
Go deeper on APEX Biologix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on APEX Biologix.